{"database": "lobbying", "table": "lobbying_activities", "rows": [[1446954, "d2a6ee41-4e40-4b98-97aa-13c8a2c74e55", "Q3", "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", 29403, "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", 2013, "third_quarter", "FOO", "Dietary SupplementsReintroduction of S. 3431 - Designer Anabolic Steroid Control Act (DASCA, 112th Congress).  Food and Drug Administration (FDA) regulation of anabolic steroids; all sections.\n\nReintroduction of H.R. 1364 - Free Speech About Science Act of 2011 (112th Congress).  Food and Drug Administration (FDA) regulation of dietary supplements labeling; all sections.\n\nFood and Drug Administration (FDA) draft \"Guidance for Industry: New Dietary Ingredient Notifications and Related Issues.\"", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE", null, 280000, 0, 0, "2013-10-17T13:54:35.443000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1446954"], "units": {}, "query_ms": 40.56787199806422, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}